Repeated inhalation of low doses of cat allergen that do not induce clinical symptoms increases bronchial hyperresponsiveness and eosinophil cationic protein levels

International Archives of Allergy and Immunology

Volumn 120, Issue 2, 1999, Pages 158-165

  De Blay, Frédéric ^a,b   Krieger, Pascale ^b   Spirlet, François ^b   Moreau, Lionel ^b   Duvernelle, Catherine ^b   Kassel, Olivier ^b   Kopferschmitt, Marie Christine ^b   Gasser, Bernard ^a,b   Demangeat, Christine ^a   Pauli, Gabrielle ^b   Frossard, Nelly ^b  

^a UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^b UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

Bronchial asthma; Bronchial hyperresponsiveness; Cat allergen; Eosinophil; Eosinophil cationic protein; Inflammation

Indexed keywords

ALLERGEN; EOSINOPHIL CATIONIC PROTEIN; METHACHOLINE;

ADULT; ARTICLE; ASTHMA; BRONCHUS HYPERREACTIVITY; CAT; CLINICAL ARTICLE; EOSINOPHIL; FEMALE; HUMAN; INHALATION; LUNG LAVAGE; MALE; PRIORITY JOURNAL; SERUM;

ADMINISTRATION, INHALATION; ALLERGENS; ANIMALS; ASTHMA; BLOOD PROTEINS; BRONCHIAL HYPERREACTIVITY; BRONCHOALVEOLAR LAVAGE FLUID; CATS; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; EOSINOPHIL GRANULE PROTEINS; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-5; RANTES; RIBONUCLEASES;

EID: 0032824697     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000024234     Document Type: Article

References (38)

1. International Consensus Report on Diagnosis and Management of Asthma. Allergy 1992; 47(suppl 13).
2. Wardlaw A, Dunnette S, Gleich G, Collins J, Kay AB: Eosinophils and mast cells in bronchoalveolar lavage in subjects with mild asthma. Relationship to bronchial hyperreactivity. Am Rev Respir Dis 1988;137:62-69.
3. Jeffery P, Wardlaw A, Melson F, Collins J, Kay AB: Bronchial biopsies in asthma. An ultrastructure quantitative study and correlation with hyperreactivity. Am Rev Respir Dis 1989;140:1745-1753.
4. Olsson I, Venge P: Cationic proteins of human granulocytes. II. Separation of the cationic proteins of the granules of leukemic myeloid cells. Blood 1974;44:235-246.
5. Adelroth E, Rosenhall L, Johansson SA. Linden M, Venge P: Inflammatory cells and eosinophilic activity in asthmatics investigated by bronchoalveolar lavage. Am Rev Respir Dis 1990;142:91-99.
6. Bousquet J, Chanez P, Lacoste JY, Barneon G, Ghavanian N, Enander I, Venge P, Ahlstedt S, Simony-Lafontaine J, Godard P, Michel FB: Eosinophilic inflammation in asthma. N Engl J Med 1990;323:1033-1039.
7. Fergusson AC. Whitelaw M, Brown H: Correlation of bronchial eosinophil and mast cell activation with bronchial hyperresponsiveness in children with asthma. J Allergy Clin Immunol 1992;90:609-613.
8. Lacoste JY, Bousquet J, Chanez P, Van Vyve T, Simony-Lafontaine J, Lequeu N, Vic P, Enander I, Godard P, Michel FB: Eosinophilic and neutrophilic inflammation in asthma, chronic bronchitis, and chronic obstructive pulmonary disease. J Allergy Clin Immunol 1993;92:537-548.
9. Fahy JV, Wong H, Liu J, Boushey HA: Comparison of samples collected by sputum induction and bronchoscopy from asthmatic and healthy subjects. Am J Crit Care Med 1995; 152:53-58.
10. Odera S, Silvestri M, Balbo A, Jovovich BO, Penna R, Crimi E, Rossi GA: Airway eosinophilic inflammation, epithelial damage, and bronchial hyperresponsiveness in patients with mild-moderate, stable asthma. Allergy 1996;51:100-107.
11. Venge P, Zetterström O, Dahl R, Roxin L, Olsson I: Low level of eosinophil cationic proteins in patients with asthma. Lancet 1977;ii:373-375.
12. Dahl R, Venge P, Olsson I: Variations of blood eosinophils and eosinophil cationic protein in serum in patients with bronchial asthma. Allergy 1978;33:211-215.
13. Pizzichini E, Pizzichini M, Efthimiadis A, Evans S, Morris M, Squillage D, Gleich G, Dolovich J, Hargreave F: Indices of airway inflammation in induced sputum: Reproducibility and validity of cell and fluid phase measurements. Am J Respir Crit Care Med 1996;154: 308-317.
14. Rak S, Lowhagen O, Venge P: The effect of immunotherapy on bronchial hyperresponsiveness and eosinophilic cationic protein in pollen-allergic patients. J Allergy Clin Immunol 1988;82:470-480.
15. de Blay F, Purohit A, Stenger R, Gries P, Hamberger C, David B, Pauli G: Serum ECP levels in perennial and periodic asthma: A prospective study. Eur Respir J 1998;11:594-598.
16. Tomassini M, Magrini L, De Petrillo G, Adriani E, Bonini S, Balsano F: Serum levels of eosinophil cationic protein in allergic diseases and natural allergen exposure. J Allergy Clin Immunol 1996;97:1350-1355.
17. Durham S, Loegering D, Dunnette S, Gleich G, Kay A: Blood eosinophils and eosinophil-derived proteins in allergic asthma. J Allergy Clin Immunol 1989;84:931-936.
18. De Monchy J, Kauffman H, Venge P, Koeter G, Jansen H, Sluiter H, De Vries K: Bronchoalveolar eosinophilia during allergen-induced late asthmatic reactions. Am Rev Respir Dis 1985; 131:373-376.
19. Aalbers R, De Monchy J, Kauffman H, Smith M, Hoekstra Y, Vrugt B, Timens W: Dynamics of eosinophil infiltration in the bronchial mucosa before and after the late asthmatic reaction. Eur Respir J 1993;6:840-847.
20. Roquet A, Ihre E, Van Hage-Hamsten M, Hallden G, Zetterström O: Allergen-induced inflammation in the nose: A comparison of acute and repeated low-dose allergen exposure. Allergy 1996;51:42-48.
21. Cockcroft D, Ruffin R, Dolovich J, Hargreave F: Allergen-induced increase in non-allergic bronchial reactivity. Clin. Allergy 1977;7:503-513.
22. Altounyan R: Changes in histamine and atropine responsiveness as a guide to diagnosis and evaluation of therapy in obstructive airways diseases; in Pepys J, Franckland AW (eds): Disodium Cromoglycate in Allergic Airways Diseases. London, Butterworth, 1970, p 47.
23. Ihre E, Zetterström O: Increase in non-specific bronchial responsiveness after repeated inhalation of low doses of allergen. Clin Exp Allergy 1993;23:298-305.
24. de Blay F, Sanchez J, Hedelin G, Perez-Infante A, Vérot A, Chapman M, Pauli G: Dust and airborne exposure to allergen derived from cockroach (Blattella germanica) in low cost public housing of Strasbourg (France). J Allergy Clin Immunol 1997;99:107-112.
25. Nieminen M: Unimodal distribution of bronchial hyperresponsiveness to methacholine in asthmatic patients. Chest 1992;102: 1537-1543.
26. National Institutes of Health Workshop Summary and Guidelines: Investigative use of bronchoscopy, lavage, and bronchial biopsies in asthma and other airway diseases. J Allergy Clin Immunol 1991;88:808-814.
27. Venge P, Roxin L, Olsson I: Radioimmunoassay of human eosinophil calionic protein. Br J Haematol 1977;37:331-335.
28. Peterson C, Enander I, Nystrand J, Anderson A, Nilsson L, Venge P: Radioimmunoassay of human eosinophil cationic protein (ECP) by an improved method. Establishment of normal levels in serum and turnover in vivo. Clin Exp Allergy 1991;21:561-567.
29. Lewis J, Wentz P, Swanson M, Reed C: Immunochemical assay of airborne cat allergen: Value in assessing variability of allergen shedding and evaluating human bronchial response. Aerobiologica 1990;6:193-196.
30. Van Metre T, Marsh D, Adkinson F, et al: Dose of cat (Felis domesticus) allergen 1 (Fel d 1) that induces asthma. J Allergy Clin Immunol 1986;78:62-75.
31. Kopferschmitt-Kubler MC, Bigot H, Pauli G: Allergen bronchial challenge tests: Variability and reproducibility of the early response. J Allergy Clin Immunol 1987;80:730-740.
32. Sulakvelidze I, Inman M, Rerecich T, O'Byrne P: Increases in airway eosinophils and interleukin-5 with minimal bronchoconstriction during repeated low-dose allergen challenge in atopic asthmatics. Eur Respir J 1998;11: 821-827.
33. Robinson D, Assoufi B, Durham S, Kay AB: Eosinophil cationic protein (ECP) and eosinophil protein X (EPX) concentrations in serum and bronchial lavage fluid in asthma. Effect of prednisolone treatment. Clin Exp Allergy 1995;25:1118-1127.
34. Boner A, Peroni D, Picentini G, Venge P: Influence of allergen avoidance at high altitude on serum markers of eosinophil activation in children with allergic asthma. Clin Exp Allergy 1993;23:1021-1026.
35. Chan-Yeung M, Leriche J, MacLean L, Lam S: Comparison of cellular and protein changes in bronchial fluid of symptomatic and asymptomatic patients with red cedar asthma on follow-up examination. Clin Allergy 1988;18: 359-365.
36. Teran L, Noso N, Carroll M, Davies D, Holgate S, Schroder J: Eosinophil recruitment following allergen challenge is associated with the release of the chemokine RANTES into asthmatic airways. J Immunol 1996;157:1806-1812.
37. Cruikshank W, Long A, Tarpy R, Kornfeld H, Carroll M, Teran L, Holgate S, Center DM: Early identification of interleukin-16 (lymphocyte chemoattractant factor) and macrophage inflammatory protein 1α (MIP1α) in bronchoalveolar lavage fluid of antigen-challenged asthmatics. Am J Respir Cell Mol Biol 1995; 13:738-741.
38. Fahy JV, Figueroa DJ, Wong HH, Abrams JS: Similar RANTES levels in healthy and asthmatic airways by immunoassay and in situ hybridization. Am J Respir Crit Care Med 1997; 155:1095-1100.